BUSI 323 Week 7 Group Discussion Board Forum 4 Example

Group Discussion Board Forum 4: Capital Budgeting for a Surgical Robot

BUSI 323 Financial Analysis and Management in Healthcare, Group Discussion Board Forum 4

Thread by [Student Name]

The hospital, its projections and the classmates are composites; the textbook, Scripture and the peer-reviewed articles cited are real.

I chose the capital budgeting prompt because our hospital's board is facing exactly this question. Our 200-bed community hospital is considering a surgical robot priced at about $2.5 million, with an annual service contract of roughly $180,000 and instrument costs on every case. The vendor projects 300 robotic cases a year by the third year, new patients drawn from competitors and shorter stays. Cleverley and Cleverley (2018) explain that capital projects should be judged by their cash flows over the asset's life, discounted to present value at the organization's cost of capital, rather than by simple payback, which ignores the timing of money and anything after the payback year.

In principle, the cash flows are straightforward to list: the purchase, installation and training at the start; service, instruments and extra operating room time each year; and in return, added revenue from new cases and any savings from shorter stays or fewer complications. The hard part is deciding which projections to believe, because a small change in annual volume or in the length of stay saved can swing the result from positive to negative.

The evidence is mixed. Shafiei et al. (2026) reviewed 180 studies of hysterectomy and found that robotic surgery offered real advantages over open surgery, but outcomes largely comparable to conventional laparoscopy, with consistently higher total hospital costs and longer operative times during the learning phase. Martinelli et al. (2026) reviewed 27 systematic reviews covering more than 110,000 colorectal patients and found comparable outcomes to laparoscopy, fewer conversions to open surgery, especially in rectal cancer and obesity, and higher upfront costs that narrowed as experience and volume grew.

Those findings matter for us. Our surgeons perform about 150 cases a year that could move to the robot, half the vendor's projection, and many are procedures our surgeons already perform laparoscopically with good results, so the robot would add cost to those cases without clear clinical gain. Using a 7% discount rate and our own realistic volumes, the seven-year net present value is negative unless volume reaches about 250 cases. Jesus told of a builder who must estimate the expense of a tower before laying the foundation (English Standard Version Bible, 2001/2016, Luke 14:28). A capital decision should be made on the hospital's own numbers, not on the volume a vendor hopes to sell. I recommended deferring the purchase until a regional partner commits shared volume, and revisiting the analysis each year as our surgeons' case mix changes.

Reply to Hannah

Hannah, you argued that the robot is worth buying even with a negative net present value because it helps recruit young surgeons who trained on robots during residency and now expect to use one. Recruiting value is real and deserves a place in the analysis, and many residency programs now train surgeons on robots, but that value should be estimated rather than assumed. Martinelli et al. (2026) found that robotic costs fall as surgeons move past the learning curve, so a hospital that recruits experienced robotic surgeons may reach break-even faster, which is a measurable benefit you could add to the cash flows as faster cost convergence. At the same time, I would be careful about the patient side of the argument. Shafiei et al. (2026) found that for many procedures robotic outcomes match laparoscopy, so patients may not choose a hospital simply because it owns a robot, and marketing that implies otherwise could overpromise and erode trust when results look the same.

Proverbs warns that the simple believe every word, while the prudent give careful thought to their steps (English Standard Version Bible, 2001/2016, Proverbs 14:15). If not, could your hospital ask candidate surgeons during interviews how many robotic cases they would realistically bring each year, and add that volume to the analysis as a scenario? A recruiting case built on specific commitments from real candidates would be far more persuasive to your board than a general claim, and it would show whether the robot is worth buying for the surgeons you can actually hire.

Reply to Owen

Owen, you suggested leasing the robot rather than buying it outright, which is a sensible way to think about risk when the volume forecast is uncertain. Leasing can reduce the upfront outlay, preserve borrowing capacity and shift some technology risk to the vendor, which matters for hospitals with thin reserves. Rhodes et al. (2023) showed hospital operating margins dropping by about five percentage points on average in 2020, showing how quickly finances can change, and Al-Amin et al. (2026) found that stronger financial performance reduced rural hospitals' risk of closure, which suggests that protecting liquidity is part of protecting the mission. For many hospitals, preserving cash has real value in a year when reimbursement or labor costs can shift suddenly. But a lease is still a binding financial commitment, and its total cost over the term is often higher, so it should be compared with buying on a present value basis using the same discount rate, including maintenance terms and any purchase option offered at the end of the term.

Ecclesiastes advises sowing in the morning and not withholding one's hand in the evening, because no one knows which will succeed (English Standard Version Bible, 2001/2016, Ecclesiastes 11:6). A lease with an exit clause might be a prudent way to test actual surgical volume before committing the hospital to ownership for the full life of the asset. Before signing, does the vendor offer a lease that can be canceled after two years without a heavy penalty, and what would the hospital owe on the instruments already purchased?

References

Al-Amin, M., Li, K. J., Rosko, M., & Guerrazzi-Young, C. (2026). Rural hospitals closures and conversions: The role of organizational characteristics and market forces. Journal of Health Organization and Management. Advance online publication. https://doi.org/10.1108/JHOM-07-2025-0429

Cleverley, W. O., & Cleverley, J. O. (2018). Essentials of health care finance (8th ed.). Jones & Bartlett Learning.

English Standard Version Bible. (2016). Crossway. (Original work published 2001)

Martinelli, S., Lucarini, A., Aurello, P., Damiani, G., & Petrucciani, N. (2026). Is robotic colorectal surgery worth the cost? An umbrella review integrating clinical outcomes, learning curve, and economic evidence. Journal of Robotic Surgery, 20(1). https://doi.org/10.1007/s11701-026-03716-8

Rhodes, J. H., Santos, T., & Young, G. (2023). The early impact of the COVID-19 pandemic on hospital finances. Journal of Healthcare Management, 68(1), 38-55. https://doi.org/10.1097/JHM-D-22-00037

Shafiei, F., Kani, F., Tarki, E., Fallahi, S., Beidokhti, N. A., Zarebian, H., Roshani, F., Falah, M. T., Abdolrazaghi, H. A., & Shokri, A. (2026). Robotic versus open (or laparoscopic) hysterectomy: A comprehensive review of clinical, surgical, and economic outcomes. Journal of Robotic Surgery, 20(1). https://doi.org/10.1007/s11701-026-04002-3